drugset / Trial / NCT00346996

Insulin Analogues and Severe Hypoglycaemia

NCT00346996

Phase 4 Completed 179 enrolled Lise Tarnow Novo Nordisk A/S · collab
RandomizedCrossoverOpen-labelTreatment

Summary

Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia

Timeline

Start
2007-05
Primary completion
2011-11
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Subcutaneous
Subject insulin aspart Protein / enzyme biologic Subcutaneous
Subject insulin detemir Protein / enzyme biologic Subcutaneous
Comparator insulin isophane Unknown Subcutaneous